Nu Skin Enterprises (NYSE:NUS) Rating Lowered to C at TheStreet

Nu Skin Enterprises (NYSE:NUS – Get Rating) was downgraded by research analysts at TheStreet from a “b” rating to a “c” rating in a research report issued to clients and investors on Thursday, TheStreetRatingsTable reports.

Separately, StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Wednesday, June 22nd. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Moderate Buy” and an average target price of $61.50.

Nu Skin Enterprises Stock Down 2.8 %

Nu Skin Enterprises stock opened at $43.35 on Thursday. The stock has a market cap of $2.18 billion, a PE ratio of 19.53 and a beta of 1.16. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.95 and a current ratio of 1.72. Nu Skin Enterprises has a one year low of $39.40 and a one year high of $56.76. The stock has a fifty day moving average of $44.22 and a 200 day moving average of $46.51.

Nu Skin Enterprises (NYSE:NUS – Get Rating) last released its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.03. Nu Skin Enterprises had a return on equity of 19.85% and a net margin of 4.57%. The business had revenue of $604.90 million during the quarter, compared to analyst estimates of $579.70 million. During the same quarter in the previous year, the company posted $0.91 earnings per share. Nu Skin Enterprises’s revenue for the quarter was down 10.7% on a year-over-year basis. As a group, sell-side analysts predict that Nu Skin Enterprises will post 3.62 EPS for the current year.

Insider Transactions at Nu Skin Enterprises

In other news, insider Joseph Y. Chang sold 16,000 shares of the company’s stock in a transaction dated Wednesday, June 1st. The stock was sold at an average price of $46.57, for a total value of $745,120.00. Following the completion of the transaction, the insider now owns 22,957 shares of the company’s stock, valued at $1,069,107.49. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, insider Joseph Y. Chang sold 16,000 shares of the company’s stock in a transaction dated Wednesday, June 1st. The stock was sold at an average price of $46.57, for a total value of $745,120.00. Following the completion of the transaction, the insider now owns 22,957 shares of the company’s stock, valued at $1,069,107.49. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman Steven Lund sold 51,300 shares of the company’s stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $43.83, for a total value of $2,248,479.00. Following the completion of the transaction, the chairman now directly owns 27,200 shares of the company’s stock, valued at approximately $1,192,176. The disclosure for this sale can be found here. Insiders sold a total of 148,143 shares of company stock valued at $6,647,717 over the last 90 days. Company insiders own 2.80% of the company’s stock.

Hedge Funds Weigh In On Nu Skin Enterprises

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUS. Allspring Global Investments Holdings LLC bought a new position in Nu Skin Enterprises during the fourth quarter valued at approximately $1,103,000. State of New Jersey Common Pension Fund D boosted its stake in Nu Skin Enterprises by 15.9% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 60,026 shares of the company’s stock valued at $3,046,000 after buying an additional 8,219 shares during the last quarter. Yousif Capital Management LLC bought a new position in Nu Skin Enterprises during the fourth quarter valued at approximately $1,417,000. Quadrant Capital Group LLC boosted its stake in Nu Skin Enterprises by 47.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock valued at $54,000 after buying an additional 342 shares during the last quarter. Finally, FDx Advisors Inc. bought a new position in Nu Skin Enterprises during the fourth quarter valued at approximately $241,000. 93.79% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.